CVS Health Corp
CVS (NYSE)
CVS Health Corp stands out as a top-performing healthcare stock, delivering a robust one-year return of 28.11%. Ideal for investors seeking reliable income, it offers a dividend yield of 3.22%, which reflects its commitment to consistent payouts. Analysts maintain strong ratings, with a median 12-month price target of $93, underscoring its favorable market position.
Pros:
- Top-performing healthcare stock
- Strong market presence
Cons:
- Recent earnings misses
- Market volatility risk
CVS Health Corp (CVS) may be a suitable investment for those looking for a combination of income and potential capital appreciation, particularly given its solid one-year return of 28.11% and a dividend yield of 3.22%. However, investors should also consider the stock's lackluster five-year performance and assess their risk tolerance and investment horizon before making a decision.